This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2012-2017.
Company Filing History:
Years Active: 2012-2017
Title: Arnd Petersen: Innovator in Allergy Research
Introduction
Arnd Petersen is a notable inventor based in Bad Segeberg, Germany. He has made significant contributions to the field of allergy research, particularly in the development of recombinant allergens. With a total of 3 patents, his work focuses on improving the diagnosis and treatment of pollen allergies.
Latest Patents
Petersen's latest patents include innovative methods for the preparation and use of recombinant variants of group 6 allergens from true grasses. One of his key inventions relates to the DNA sequence and preparation of the grass pollen allergen Phl p 4. This invention is characterized by reduced IgE reactivity compared to known wild-type allergens while retaining substantial reactivity with T-lymphocytes. Additionally, he has provided the genetic sequence of the major grass pollen allergen Phl p 4, which includes fragments, new combinations of partial sequences, and point mutants that exhibit hypoallergenic properties. These recombinant DNA molecules and derived polypeptides can be utilized for the therapy of pollen-allergic diseases, as well as for in vitro and in vivo diagnosis of pollen allergies.
Career Highlights
Arnd Petersen is currently associated with Merck Patent GmbH, where he continues to advance his research in allergy treatment. His work has been instrumental in developing new therapeutic approaches for individuals suffering from pollen allergies.
Collaborations
Petersen has collaborated with notable colleagues such as Helmut Fiebig and Andreas Nandy, contributing to the advancement of allergy research through teamwork and shared expertise.
Conclusion
Arnd Petersen's innovative work in the field of allergy research has led to significant advancements in the understanding and treatment of pollen allergies. His contributions through patents and collaborations highlight his commitment to improving the lives of those affected by allergic conditions.